| 注册
首页|期刊导航|中国现代中药|2023-2024年中国黄芪种植产业调研报告

2023-2024年中国黄芪种植产业调研报告

郭宝林 潘诚 李雅妮 王玉龙 郭娇娇 李安平 张卫东

中国现代中药2025,Vol.27Issue(10):1813-1819,7.
中国现代中药2025,Vol.27Issue(10):1813-1819,7.DOI:10.13313/j.issn.1673-4890.20250314007

2023-2024年中国黄芪种植产业调研报告

Research Report on Cultivation Industry of Astragali Radix in China from 2023 to 2024

郭宝林 1潘诚 1李雅妮 2王玉龙 2郭娇娇 2李安平 2张卫东1

作者信息

  • 1. 中国医学科学院 北京协和医学院 药用植物研究所,北京 100193
  • 2. 山西振东道地药材公司,山西 长治 047100
  • 折叠

摘要

Abstract

Astragali Radix(Huangqi),a traditional Qi-tonifying herb recognized as both a food and medicinal substance,holds significant value in traditional Chinese medicine and the health industry.Based on systematic investigations of major Astragalus Radix cultivation regions in China(Gansu,Inner Mongolia,Shanxi,etc.)conducted from 2023 to 2024,this study analyzes its cultivation modes,cultivation and production status in major regions,and industrial development trends.Key findings are as follows:1)Current production is predominantly dominated by Astragalus membranaceus var.mongholicus,while A.membranaceus is rarely cultivated;2)Astragali Radix is divided into two types based on different cultivation modes:wild-simulated Astragali Radix(harvested after 6 years,primarily in Shanxi Hengshan mountain range and Shaanxi Zizhou)and short-cycle Astragali Radix(transplanted and harvested after 2 years,mainly in Gansu and Inner Mongolia).The former exhibits superior quality and commands higher prices but faces industrial development bottlenecks,while the latter accounts for over 95%of total production;3)The primary use of Astragali Radix is for human medicines(as decoction pieces and Chinese traditional patent medicines),with growing demand in veterinary medicine,feed additives,health food,and functional food ingredients.Notably,veterinary-use Astragalus Radix polysaccharide demand has surged under the influence of"antibiotic replacement"policy in China;4)The translocation of production areas due to factors such as continuous cropping obstacles has led to variations in medicinal quality,hybridization of germplasm resources(between A.membranaceus var.mongholicus and A.membranaceus),and the lack of quality standards for wild-simulated Astragali Radix in genuine medicinal materials.These issues pose major challenges to the sustainable development of the Astragalus Radix cultivation industry.It is recommended to enhance germplasm resources purification and variety breeding,establish quality standards of genuine medicinal materials,optimize crop rotation systems,and guide orderly development of production regions to foster sustainable industry growth.

关键词

黄芪/种植产业/调研报告

Key words

Astragali Radix/cultivation industry/research report

分类

中医学

引用本文复制引用

郭宝林,潘诚,李雅妮,王玉龙,郭娇娇,李安平,张卫东..2023-2024年中国黄芪种植产业调研报告[J].中国现代中药,2025,27(10):1813-1819,7.

基金项目

国家自然科学基金项目(82430119) (82430119)

中国现代中药

1673-4890

访问量0
|
下载量0
段落导航相关论文